Oncovita has been granted the exclusive license to an immuno-oncolytic measles virus platform developed by the...
Up To Date
Latest News
Boehringer Ingelheim has licenced a preclinical fusion protein from Korean Yuhan Corp. that activates both...
A French-Swiss research team is developing a “smart bra” for detecting breast cancer more accessible than...
GARDP has called up the global community to develop and deliver five new treatments that break antimicrobial...